The High Flow Oxygen Therapy Study
Completed
- Conditions
- Hypoxia.Blood - Other blood disorders
- Registration Number
- ACTRN12606000139572
- Lead Sponsor
- Fisher and Paykel Healthcare
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Consent has been obtained or is likely to be obtained- Patient currently on oxygen therapy via nasal prongs or mask- In the opinion of the treating clinical team the patient has sub optimal gas exchange and/or the patient is in a degree of mild respiratory distress.
Exclusion Criteria
The patient is likely to require imminent intubation (within 30mins)- The patient has a tracheostomy in situ- Patient would not be offered mechanical/non invasive ventilation due to clinical condition/prognosis- The patient has previously been enrolled in this study- The patient has already been treated with high flow nasal oxygen in the CVICU or Ward 42 this admission- Contraindication to high flow nasal oxygen.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method